Related Experiment Videos

Retarding the progression of renal disease

Barry M Brenner¹

¹Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.

Kidney International

|June 6, 2003

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Climate change and its influence in nephron mass.

Current opinion in nephrology and hypertension·2023

Clinical consequences of developmental programming of low nephron number.

Anatomical record (Hoboken, N.J. : 2007)·2019

Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups.

Circulation·2019

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.

The New England journal of medicine·2019

N-terminal pro-brain natriuretic peptide (NT-proBNP) predicts the cardio-renal response to aliskiren in patients with type 2 diabetes at high renal and cardiovascular risk.

Diabetes, obesity & metabolism·2018

The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics.

American journal of nephrology·2017

See all related articles